Vulvar vestibulitis syndrome and estrogen dose of oral contraceptive pills.

Introduction: Vulvar vestibulitis syndrome (VVS) is a diverse, multifactorial phenomenon. Its precise etiology is unknown.

Aim: To define the association between oral contraceptive (OC) estrogen dosage and VVS.

Hyperoxaluria in women with vulvar vestibulitis syndrome.

Objective: To determine whether evaluation and treatment of hyperoxaluria in vulvar vestibulitis syndrome (VVS) is justified.

Study Design: Forty women (mean age, 24.5 years; range, 18-35) diagnosed with VVS at a sex therapy clinic participated.